Neuronal ceroid lipofuscinosis in qatar: Report of a novel mutation in ceroid-lipofuscinosis, neuronal 5 in the arab population

Moza K. Al-Kowari, Sara Hassan, Mahmoud F. El-Said, Tawfeg Ben-Omran, Lars Hedin, Sara E. Mole, Ramin Badii

Research output: Contribution to journalArticle

5 Citations (Scopus)


This study sought to genetically define the first family diagnosed with neuronal ceroid lipofuscinosis from Qatar. Onset was in late infancy (3 years), and sequencing in the affected children revealed a novel homozygous c.613C>T change in exon 3 of ceroid-lipofuscinosis, neuronal 5, corresponding to a missense mutation of a conserved amino acid, p.Pro205Ser. The clinical manifestations of the disease in this family largely resemble those of ceroid-lipofuscinosis, neuronal 5 disease, variant late infantile that was first described in Finland and include mental decline, visual deterioration, ataxia, and epileptic seizures. This description of ceroid-lipofuscinosis, neuronal 5 disease in an Arab family adds to the clinical and molecular diversity of the variant late-infantile neuronal ceroid lipofuscinoses, which were originally reported in Europe and are increasingly recognized in other populations.

Original languageEnglish
Pages (from-to)625-629
Number of pages5
JournalJournal of Child Neurology
Issue number5
Publication statusPublished - 1 May 2011



  • Arab
  • ceroid-lipofuscinosis neuronal 5
  • late-infantile neuronal ceroid lipofuscinosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this